Barclays PLC cut its holdings in The Allstate Co. (NYSE:ALL - Free Report) by 16.7% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 840,381 shares of the insurance provider's stock after selling 169,044 shares during the period. Barclays PLC owned about 0.32% of Allstate worth $159,377,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently made changes to their positions in ALL. LRI Investments LLC lifted its holdings in Allstate by 334.8% during the 3rd quarter. LRI Investments LLC now owns 17,388 shares of the insurance provider's stock valued at $3,298,000 after buying an additional 13,389 shares in the last quarter. PYA Waltman Capital LLC grew its position in shares of Allstate by 3.5% during the 3rd quarter. PYA Waltman Capital LLC now owns 15,238 shares of the insurance provider's stock worth $2,890,000 after buying an additional 520 shares in the last quarter. SGL Investment Advisors Inc. purchased a new position in shares of Allstate during the third quarter valued at $545,000. EWA LLC bought a new stake in shares of Allstate in the third quarter valued at about $242,000. Finally, Nomura Asset Management Co. Ltd. lifted its stake in Allstate by 25.4% in the third quarter. Nomura Asset Management Co. Ltd. now owns 94,174 shares of the insurance provider's stock worth $17,860,000 after acquiring an additional 19,093 shares during the period. Institutional investors own 76.47% of the company's stock.
Wall Street Analyst Weigh In
ALL has been the topic of a number of recent research reports. BMO Capital Markets increased their price objective on shares of Allstate from $205.00 to $214.00 and gave the company an "outperform" rating in a research note on Friday, October 18th. UBS Group lifted their price target on Allstate from $216.00 to $225.00 and gave the company a "buy" rating in a report on Monday, November 4th. Bank of America upped their price objective on Allstate from $216.00 to $233.00 and gave the stock a "buy" rating in a research note on Friday, October 18th. Raymond James lifted their target price on Allstate from $205.00 to $220.00 and gave the company a "strong-buy" rating in a research note on Friday, October 4th. Finally, The Goldman Sachs Group boosted their price objective on shares of Allstate from $209.00 to $230.00 and gave the stock a "buy" rating in a research note on Friday, November 15th. One research analyst has rated the stock with a sell rating, two have given a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, Allstate currently has a consensus rating of "Moderate Buy" and an average price target of $217.19.
Read Our Latest Report on Allstate
Insider Buying and Selling at Allstate
In related news, insider John E. Dugenske sold 36,367 shares of Allstate stock in a transaction dated Friday, September 20th. The stock was sold at an average price of $191.38, for a total transaction of $6,959,916.46. Following the transaction, the insider now directly owns 27,364 shares of the company's stock, valued at $5,236,922.32. The trade was a 57.06 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.80% of the stock is owned by company insiders.
Allstate Trading Down 0.9 %
ALL traded down $1.84 on Wednesday, reaching $193.22. 1,541,433 shares of the company's stock were exchanged, compared to its average volume of 1,551,107. The Allstate Co. has a twelve month low of $134.17 and a twelve month high of $209.88. The company's 50 day moving average is $194.69 and its 200-day moving average is $180.92. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.40 and a current ratio of 0.40. The company has a market cap of $51.16 billion, a price-to-earnings ratio of 12.52, a PEG ratio of 1.79 and a beta of 0.50.
Allstate (NYSE:ALL - Get Free Report) last posted its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $3.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.20 by $1.71. The firm had revenue of $16.63 billion for the quarter, compared to analysts' expectations of $14.57 billion. Allstate had a net margin of 6.77% and a return on equity of 26.67%. The firm's quarterly revenue was up 14.7% on a year-over-year basis. During the same period in the prior year, the company posted $0.81 earnings per share. Equities analysts predict that The Allstate Co. will post 16.26 earnings per share for the current year.
Allstate Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Thursday, January 2nd. Stockholders of record on Friday, November 29th will be given a dividend of $0.92 per share. The ex-dividend date of this dividend is Friday, November 29th. This represents a $3.68 annualized dividend and a dividend yield of 1.90%. Allstate's dividend payout ratio is currently 23.83%.
About Allstate
(
Free Report)
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
See Also
Before you consider Allstate, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allstate wasn't on the list.
While Allstate currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.